| abstract |
FIELD: pharmaceutics. n SUBSTANCE: invention relates to pharmaceutical industry and represents rectal polycomplex gel for treatment of ulcerative colitis, Crohn's disease, fistulas and complications, caused by these diseases characterized by that it contains metronidazole, timogen, carbopol, propylene glycol, disodium EDTA, propyl parahydroxybenzoate, methyl parahydroxybenzoate, sodium hydroxide and water, wherein ingredients of gel are taken in certain proportions, g/150 g. n EFFECT: invention provides higher clinical effectiveness in treatment of non-infectious inflammatory diseases of intestinal-digestive tract, reduced length of treatment. n 1 cl, 3 ex, 3 tbl |